QQ客服 官方微博 反馈留言

浏览/检索结果: 共6条，第1-6条 帮助 已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Optimization of ODAP-Urea-based dual-modality PSMA targeting probes for sequential PET-CT and optical imaging 期刊论文 BIOORGANIC & MEDICINAL CHEMISTRY, 2022, 卷号: 66, 页码: 10 作者:  Li, Yuan;  Duan, Xiaojiang;  Xu, Hongchuang;  Zhang, Jingming;  Zhou, Haoxi 收藏  |  浏览/下载：27/0  |  提交时间：2022/07/25 Prostate cancer  Prostate-specific membrane antigen (PSMA)  Dual-modality imaging  PET imaging  Optical imaging   First-in-human study of Lu-177-EB-PSMA-617 in patients with metastatic castration-resistant prostate cancer 期刊论文 2019, 卷号: 46, 期号: 1, 页码: 148-158 作者:  Zang, Jie;  Fan, Xinrong;  Wang, Hao;  Liu, Qingxing;  Wang, Jingnan 收藏  |  浏览/下载：27/0  |  提交时间：2020/01/03 Radioligand therapy (RLT)  Lu-177  Evans blue  Prostate-specific membrane antigen (PSMA)  Metastatic castration-resistant prostate cancer (mCRPC)   Pretherapeutic Ga-68-PSMA-617 PET May Indicate the Dosimetry of Lu-177-PSMA-617 and Lu-177-EB-PSMA-617 in Main Organs and Tumor Lesions 期刊论文 2019, 卷号: 44, 期号: 6, 页码: 431-438 作者:  Wang, Jingnan;  Zang, Jie;  Wang, Hao;  Liu, Qingxing;  Li, Fang 收藏  |  浏览/下载：15/0  |  提交时间：2020/01/03 Ga-68  Lu-177  prostate-specific membrane antigen (PSMA)  metastatic castration-resistant prostate cancer (mCRPC)  dosimetry   Fluorescent chemical probes for accurate tumor diagnosis and targeting therapy 期刊论文 CHEMICAL SOCIETY REVIEWS, 2017, 卷号: 46, 期号: 8, 页码: 2237-2271 作者:  Gao, Min;  Yu, Fabiao;  Lv, Changjun;  Choo, Jaebum;  Chen, Lingxin 收藏  |  浏览/下载：244/0  |  提交时间：2017/06/21 NEAR-INFRARED FLUORESCENCE  AGGREGATION-INDUCED-EMISSION  CARBONIC-ANHYDRASE-IX  GROWTH-FACTOR RECEPTOR  CHOLECYSTOKININ-B/GASTRIN RECEPTORS  THERANOSTIC PLATINUM(IV) PRODRUG  OPTICAL IMAGING PROBES  MEMBRANE ANTIGEN PSMA  LOW-MOLECULAR-WEIGHT  BREAST-CANCER CELLS   Targeted delivery of CRISPR/Cas9 to prostate cancer by modified gRNA using a flexible aptamer-cationic liposome 期刊论文 ONCOTARGET, 2017, 卷号: 8, 页码: 9375-9387 作者:  Zhen, Shuai;  Takahashi, Yoichiro;  Narita, Shunichi;  Yang, Yi-Chen;  Li, Xu 收藏  |  浏览/下载：10/0  |  提交时间：2019/11/26 CRISPR/Cas9 delivery  polo-like kinase 1 (PLK1)  prostate cancer  prostate-specific membrane antigen (PSMA)  aptamer-liposome chimera   Aptamer-mediated delivery of docetaxel to prostate cancer through polymeric nanoparticles for enhancement of antitumor efficacy 期刊论文 EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2016, 卷号: 107 作者:  Chen, Zhongjian;  Tai, Zongguang;  Gu, Fenfen;  Hu, Chuling;  Zhu, Quangang 收藏  |  浏览/下载：14/0  |  提交时间：2019/12/05 Docetaxel  Prostate cancer  Aptamer  Prostate specific membrane antigen (PSMA)  Targeted drug delivery  Antitumor efficacy